Price target upside
ADMA Biologics Inc - Common Stock Price Target Upside or Downside
ADMA price target upside based on the current price and analyst average.
Direct answer
ADMA Biologics Inc - Common Stock's analyst target implies +90.8%.
The average target is $17.00 compared with a recorded current price of $8.91.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $8.91
- Average price target
- $17.00
- High price target
- $21.00
- Low price target
- $12.00
- Target upside
- +90.8%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026